Management of Pediatric Asthma: An Integrative Review of Key Treatments
DOI:
https://doi.org/10.36557/2674-8169.2023v5n5p5156-5169Keywords:
Asma Pediátrica; Manejo; Revisão Integrativa.Abstract
This in-depth study aims to meticulously examine the management of asthma in children, focusing on an integrative review of predominant treatments. Pediatric asthma, owing to its unique characteristics and the dynamism of childhood development, presents specific challenges that necessitate a comprehensive and multifaceted analysis of available therapeutic options. The review not only highlights the variety of pharmacological interventions but also delves into the realm of non-pharmacological therapies, recognizing that an effective approach often extends beyond the isolated use of medications.
Within the pharmacological scope, the analysis explores distinct classes of medications, assessing their relative efficacies, safety considerations, and potential specific side effects in asthmatic children. Simultaneously, non-pharmacological therapies such as lifestyle modifications, physical therapy, and psychosocial interventions are addressed, emphasizing the importance of a holistic approach that considers the patient as a whole. The integrative focus aims to provide a comprehensive understanding of available treatment options and their practical applicability.
In the context of the integrative review, it is crucial to underscore the need for a personalized approach to asthma management in children. This implies a careful consideration of individual, environmental, and genetic factors that may influence treatment response. A deeper understanding of these elements will contribute to the development of more targeted and tailored intervention strategies for each pediatric asthmatic patient, promoting a truly personalized approach.
In summary, this work proposes a critical and comprehensive analysis of pediatric asthma management, highlighting not only the available treatment options but also the importance of integrative strategies to optimize clinical outcomes and significantly improve the quality of life for children affected by this chronic respiratory condition.
Downloads
References
Agache, I. et al. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma. Allergy, v. 75, p. 1058–1068, 2020.
Dai, J. et al. Noninvasive positive-pressure ventilation for children with acute asthma: a meta-analysis of randomized controlled trials. Front. Pediatr., v. 11, p. 1167506, 2023.
Drago, L. et al. The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706). Journal of Immunology Research, v. 2022, p. 7, 2022.
Jackson, D. J. et al. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma. Ann Allergy Asthma Immunol, v. 131, p. 44−51, 2023.
Jentzsch, N. S. et al. Treatment adherence and level of control in moderate persistent asthma in children and adolescents treated with fluticasone and salmeterol. J Pediatr (Rio J), v. 95, p. 69–75, 2019.
Nieto García, A. et al. Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma. Pediatr Allergy Immunol., v. 32, p. 980–991, 2021.
Rodriguez-Martinez, C. E. et al. The use of ipratropium bromide for treating moderate to severe asthma exacerbations in pediatric patients in an emergency setting: A cost‐effectiveness analysis. Pediatric Pulmonology, v. 56, p. 3706–3713, 2021.
Tayyab, A. et al. Effectiveness of single dose oral dexamethasone versus multidose prednisolone for treatment of acute exacerbations of asthma among children. Annals of Medicine and Surgery, v. 84, 104799, 2022.
Wang, X. et al. Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta‐analysis. Pediatric Pulmonology, v. 55, p. 1936–1945, 2020.
Yua T. et al. Inhibition of CREB promotes glucocorticoids action on airway inflammation in pediatric asthma by promoting ferroptosis of eosinophils. Allergol Immunopathol (Madr), v. 51, n. 4, p. 164–174, 2023.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Cintia Alves Barros , Ingrid Bouillet Maia, Jéssica Mendes Allan Pinto , Rachel Conceição Moniz, Edenizar Gomes de Freitas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are copyright holders under a CCBY 4.0 license.
